Astrazeneca Pharma India Ltd (ASTRAZEN) — Announcement | 15 September 2026 (2 announcements)

15 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

1Announcement🔴 High Importance Neutral📄 PDF

📢 Key Event

Senior management resignation disclosed per SEBI Listing Regulation 30

💡 Investor Takeaway

This leadership change may temporarily affect execution of medical affairs strategies.

AstraZeneca Pharma India announced the resignation of Dr. Sandeep Arora, Director of Medical Affairs and Rare Disease Business Unit, effective September 15, 2026, to pursue external career opportunities. The board is already searching for his successor, and the filing complies with SEBI Listing Regulation 30 requirements, including mandatory disclosures and an attached resignation letter.

2Announcement Neutral📄 PDF

📢 Key Event

Trading window closure announced for insider compliance

💡 Investor Takeaway

Shareholders must avoid trading company stock during the closed window to prevent insider trading violations.

AstraZeneca Pharma India Ltd announced that its trading window will close on September 16, 2026, to comply with insider trading regulations, remaining shut until 48 hours after the un-audited quarterly results for September 30, 2026 are released. This restriction limits insider transactions during a critical reporting period.

📊 Stock Analysis — ASTRAZEN ✨ Ask AI About This

About Astrazeneca Pharma India Ltd (ASTRAZEN)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹15,635.88 CrP/E: 92.2ROE: 19.4%ROCE: 26.8%Div Yield: 0.58%

View full ASTRAZEN stock details →

📡 Get AI alerts when ASTRAZEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ASTRAZEN — Free

💡 Ask AI about this filing

"How is the successor search progressing and what is the timeline?""What is the potential impact on medical affairs operations?""Are there any compensation or severance details disclosed?"

Ask AI Free →

📊 More ASTRAZEN filings

🔴 Announcement — 18 September 2026AstraZeneca Pharma India disclosed a penalty of Rs.1.88 lakh imposed by the Registrar of Companies f...
🔴 Announcement — 2 September 2026AstraZeneca Pharma India disclosed its ESG rating of 64 from Crisil ESG Ratings, based on FY2026 pub...
Announcement — 25 August 2026AstraZeneca Pharma India Limited disclosed that the Delhi High Court stayed an NPPA demand notice al...
Announcement — 24 August 2026AstraZeneca Pharma India Limited disclosed its ESG rating of 57 from Crisil ESG Ratings, based on pu...
Announcement — 21 August 2026AstraZeneca Pharma India Limited announced a scheduled one-on-one virtual meeting with an institutio...

See all ASTRAZEN filings →

🔥 Also filed on 15 September 2026

MUTHOOTMFMuthoot Microfin LtdCorporate Action JUBLFOODJubilant Foodworks LtdAnnouncement 523467Jai Mata Glass LtdOffer Document BLUECLOUDSBlue Cloud Softech Solutions LtdAnnouncement FREDUNFredun Pharmaceuticals LtdAnnouncement IZMOIZMO LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ASTRAZEN files new disclosures

Track ASTRAZEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.